Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_assertion type Assertion NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_head.
- NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_assertion description "[Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia, and the graft-vs-leukemia (GVL) effect can eradicate residual leukemia after allo-SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_provenance.
- NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_assertion evidence source_evidence_literature NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_provenance.
- NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_assertion SIO_000772 22665066 NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_provenance.
- NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_assertion wasDerivedFrom befree-20140225 NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_provenance.
- NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_assertion wasGeneratedBy ECO_0000203 NP938825.RAE4-mMdyM7Dee32vp22-HprUwp0Sv1lxM2COaGyfqILE130_provenance.